Geron Corp. XNAS: GERN

Geron Corp. Live Share Price Today, Share Analysis and Chart

about

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of...

Read More

1.53 -0.01 (-0.65%)

71.35% Fall from 52W High

5.5M XNAS Volume

XNAS 05 Jun, 2025 2:09 PM (EDT)

Low Financial Strength
33.3 / 100
Expensive Valuation
12.3 / 100
Technically Neutral
36.3 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

Geron Corp. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Geron Corp. FAQ

How is Geron Corp. today?
Geron Corp. today is trading in the red, and is down by -0.65% at 1.53.
Geron Corp. is currently trading down -0.65% on an intraday basis. In the past week the stock rose 5.52%. stock has been down -7.83% in the past quarter and fell -61.65% in the past year. You can view this in the overview section.